Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's (NVRO) stock for $5.85 per share in cash. The price ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...

On Thursday, Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE:GMED) stock following ...

Nevro NVRO shares ended the last trading session ... One other stock in the same industry, Globus Medical GMED, finished the last trading session 2% higher at $78.59. GMED has returned 4.3% ...

Meanwhile, NVRO currently has a market capitalization ... has an estimated long-term growth rate of 12.7%. GMED’s earnings surpassed estimates in each of the trailing four quarters, delivering ...

Nevro Corp. NVRO is well-poised for growth in the coming ... has an estimated long-term growth rate of 11.2%. GMED’s earnings surpassed estimates in three of the trailing four quarters and ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Globus Medical (GMED – Research Report) and Nevro Corp (NVRO – Research Report). See what stocks are receiving ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

On Thursday, Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE: GMED) stock following the company’s announcement of acquiring Nevro Corp . (NYSE: NVRO) for an ...

Stifel maintains GMED buy rating, $92 target amid NVRO buyout View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks US 30 ...

Stifel maintains GMED buy rating, $92 target amid NVRO buyout ...